William N. Hait - Concepedia

Author

William N. Hait

Rutgers, The State University of New Jersey

Also Known As

, Hait, William N., W N Hait, WILLIAM N. HAIT, William Hait, William N Hait, William N. Hait

145

Publications

Citations

H-Index

Concepts

All Affiliations

Rutgers, The State University of New Jersey Rutgers Cancer Institute Yale University Johnson University Yale Cancer Center

About

William N. Hait is an author at Rutgers, The State University of New Jersey specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	38	2.4K
2	Natural Sciences	6	6	264
3	Health Sciences	4	4	199
4	Engineering	1	1	47
5	Public Health	1	1	47

William N. Hait

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer Robert S. DiPaola, Huayan Zhang, George H. Lambert, New England Journal of Medicine	1998	294
Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Hao Wu, William N. Hait, Jin-Ming Yang PubMed Tumor BiologySystems BiologyMdr1 Gene ProductRna InterferenceMedicine	2003	291
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner Gareth L. Bond, Kim M. Hirshfield, Tomas Kirchhoff, Cancer Research	2006	286
Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase Alexey G. Ryazanov, Michael D. Ward, Charmaine E. Mendola, Proceedings of the National Academy of Sciences	1997	212
The CD44 Receptor Interacts with P-Glycoprotein to Promote Cell Migration and Invasion in Cancer Karl E. Miletti-González, Shiling Chen, N. Muthukumaran, Cancer Research	2005	207
AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development Samir N. Khleif, James H. Doroshow, William N. Hait Clinical Cancer Research Cancer ManagementPathologyCancer RegistrationTumor BiologyBiomarker (Medicine)	2010	186
Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Elizabeth Alli, Judy Bash-Babula, Jin Yang, PubMed Breast OncologyMedicineCancer Cell BiologyHuman Breast CancerCell Lines	2002	184
Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Jin Yang, Zu‐De Xu, Hao Wu, PubMed OncologyMedicineMdr Cancer CellsPharmacologyCancer Cell Biology	2003	165
The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells Christine C Zhang, Jinming Yang, Eileen White, Oncogene MedicineMap4 ExpressionP53 Mutant CellsAnti-cancer AgentCell Biology	1998	157
Transforming Cancer Prevention through Precision Medicine and Immune-oncology Thomas W. Kensler, Avrum Spira, Judy E. Garber, Cancer Prevention Research	2016	150

Page 1